TY - JOUR
T1 - Synthesis, molecular docking and in vitro antimicrobial studies of novel pyrazole analogues of curcumin
AU - Kumar, Dileep
AU - Harish, B. G.
AU - Gangwar, Mayank
AU - Kumar, Manish
AU - Kumar, Dharmendra
AU - Tilak, Ragini
AU - Nath, Gopal
AU - Kumar, Ashok
AU - Singh, Sushil Kumar
PY - 2014/5
Y1 - 2014/5
N2 - A series of pyrazole analogues of curcumin were synthesized and investigated for in vitro and in silico antimicrobial activity. The structures of newly synthesized compounds were ascertained on the basis of their analytical and spectral profiles. The compounds were subjected to molecular docking studies for the inhibition of the enzyme glucosamine-6- phosphate synthase [GlcN-6-P]. The autodock program 4.2 was employed to perform automated molecular docking. The docking study was performed on two different active sites of the enzyme reside with the amino acid series Cys1, Arg73, Thr76, His77, Asn98, Gly99, Ile100 and Gly301, Thr302, Ser303, Ser347, Gln348, Ser349, Thr352, Lys485, Ala602, Val605 respectively. Among the thirteen molecules taken for docking studies, compounds cp10, cp11 and cp12 showed minimum docking energy and inhibition constant and may be considered as good inhibitor of GlcN-6-P synthase.
AB - A series of pyrazole analogues of curcumin were synthesized and investigated for in vitro and in silico antimicrobial activity. The structures of newly synthesized compounds were ascertained on the basis of their analytical and spectral profiles. The compounds were subjected to molecular docking studies for the inhibition of the enzyme glucosamine-6- phosphate synthase [GlcN-6-P]. The autodock program 4.2 was employed to perform automated molecular docking. The docking study was performed on two different active sites of the enzyme reside with the amino acid series Cys1, Arg73, Thr76, His77, Asn98, Gly99, Ile100 and Gly301, Thr302, Ser303, Ser347, Gln348, Ser349, Thr352, Lys485, Ala602, Val605 respectively. Among the thirteen molecules taken for docking studies, compounds cp10, cp11 and cp12 showed minimum docking energy and inhibition constant and may be considered as good inhibitor of GlcN-6-P synthase.
UR - https://www.scopus.com/pages/publications/84898732317
UR - https://www.scopus.com/pages/publications/84898732317#tab=citedBy
U2 - 10.2174/15701808113106660087
DO - 10.2174/15701808113106660087
M3 - Article
AN - SCOPUS:84898732317
SN - 1570-1808
VL - 11
SP - 474
EP - 483
JO - Letters in Drug Design and Discovery
JF - Letters in Drug Design and Discovery
IS - 4
ER -